Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakris

Showing results (201-210 of 991) with videos related to

Pageof 100
Sort By:
Journal of Diabetes and Its Complications|March 1, 1997
Renal mortality associated with non-insulin-dependent diabetes mellitusP Kilaru, G L Bakris
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 11, 2008
Executive summary: Kidney Early Evaluation Program (KEEP) 2007 Annual Data ReportGeorge Bakris, Allan J Collins
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 5, 2003
Are antihypertensive drugs used to maximally reduce cardiovascular risk in dialysis patients?Jay Garg, George L Bakris
Current Cardiology Reports|January 23, 2013
Chronic kidney disease as a coronary artery disease risk equivalentAlexandrios Briasoulis, George L Bakris
Current Hypertension Reports|April 19, 2013
Role of ambulatory blood pressure monitoring in hypertension and diabetesColleen Flynn, George L Bakris
Postgraduate Medicine|December 1, 1993
Drug dosing in patients with renal insufficiency. A simplified approachG L Bakris, R Talbert
Journal of Clinical Pharmacology|September 7, 2000
Evolution of drugs that preserve renal functionE Basta, G L Bakris
Current Hypertension Reports|February 13, 2019
Blood Pressure Lowering and Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2is): More Than Osmotic DiuresisHillel Sternlicht, George L Bakris
Current Hypertension Reports|May 11, 2002
Angiotensin converting enzyme inhibitors or angiotensin receptor blockers in nephropathy from type 2 diabetesJay Garg, George L Bakris
The Medical Clinics of North America|November 26, 2016
The Kidney in HypertensionHillel Sternlicht, George L Bakris
Pageof 100

Showing results (201-210 of 991) with videos related to

Sort By:
Pageof 100
Journal of Diabetes and Its Complications|March 1, 1997
Renal mortality associated with non-insulin-dependent diabetes mellitusP Kilaru, G L Bakris
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 11, 2008
Executive summary: Kidney Early Evaluation Program (KEEP) 2007 Annual Data ReportGeorge Bakris, Allan J Collins
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 5, 2003
Are antihypertensive drugs used to maximally reduce cardiovascular risk in dialysis patients?Jay Garg, George L Bakris
Current Cardiology Reports|January 23, 2013
Chronic kidney disease as a coronary artery disease risk equivalentAlexandrios Briasoulis, George L Bakris
Current Hypertension Reports|April 19, 2013
Role of ambulatory blood pressure monitoring in hypertension and diabetesColleen Flynn, George L Bakris
Postgraduate Medicine|December 1, 1993
Drug dosing in patients with renal insufficiency. A simplified approachG L Bakris, R Talbert
Journal of Clinical Pharmacology|September 7, 2000
Evolution of drugs that preserve renal functionE Basta, G L Bakris
Current Hypertension Reports|February 13, 2019
Blood Pressure Lowering and Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2is): More Than Osmotic DiuresisHillel Sternlicht, George L Bakris
Current Hypertension Reports|May 11, 2002
Angiotensin converting enzyme inhibitors or angiotensin receptor blockers in nephropathy from type 2 diabetesJay Garg, George L Bakris
The Medical Clinics of North America|November 26, 2016
The Kidney in HypertensionHillel Sternlicht, George L Bakris
Pageof 100